Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive care, reflecting the dynamic challenges and opportunities in our field. In our first editorial, Barbara […]

Carlos Chaccour, ISNTD d3 2021: Ivermectin for COVID-19

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 22nd 2021

It was a delight to be able to speak with Dr Carlos Chaccour (University of Barcelona, Barcelona, Spain) about the controversy currently surrounding the use of ivermectin for the treatment of COVID-19.

His presentation entitled Ivermectin and COVID: what’s going on?  was presented at the ISNTD d3 2021 Virtual Congress, 24-25 February.

Questions:

  1. Could you give us a brief overview of the controversy surrounding the use of ivermectin for the treatment of COVID-19? (0:49)
  2. What evidence has been generated to date to help support the case for and against the drug’s use? (3:53)
  3. What further evidence is emerging on the efficacy of ivermectin in this indication? (6:36)

Disclosures: Dr Carlos Chaccour has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media

Filmed in coverage of ISNTD d3 2021 Virtual Conference.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup